06.27.14
According to the Journal Gazette, a Fort Wayne, Ind. newspaper, DePuy Synthes has eliminated an “undisclosed” number of jobs in the Hoosier state. The cuts will affect the West Chester, Pa.-base company’s Warsaw office.
Lorie Gawreluk, vice president of worldwide communications, told the Journal Gazette that less than 2 percent of the company’s 23,000-person global workforce is affected by the job eliminations. Two percent would be 460 jobs.
“The impact of the job changes is global and across many sites and areas of our business,” Gawreluk said, declining to be more specific about the number of jobs lost in Warsaw. She also declined to provide an exact Warsaw employee headcount.
DePuy employed about 1,200 in the Kosciusko County city as of two years ago.
The company is reorganizing to respond to economic and health care changes, Gawreluk said in her email to the newspaper.
DePuy Synthes, she wrote, will offer more products to hospitals, improve innovation, offer expert guidance to orthopedic surgeons and cut costs, among other goals.
“As we transform our operating model, the majority of our employee roles won’t change or will change minimally. New roles are being created and other roles are being eliminated,” she wrote, adding that about 80 new positions have been created to help the company execute its new strategy.
Gawreluk declined to say how many of those new jobs will be in Warsaw.
“We hope impacted employees will strongly consider these positions as well as career opportunities across Johnson & Johnson,” she said. DePuy Synthes is a Johnson & Johnson company.
For those whose jobs are eliminated, the company is offering severance benefits and job placement assistance.
Lorie Gawreluk, vice president of worldwide communications, told the Journal Gazette that less than 2 percent of the company’s 23,000-person global workforce is affected by the job eliminations. Two percent would be 460 jobs.
“The impact of the job changes is global and across many sites and areas of our business,” Gawreluk said, declining to be more specific about the number of jobs lost in Warsaw. She also declined to provide an exact Warsaw employee headcount.
DePuy employed about 1,200 in the Kosciusko County city as of two years ago.
The company is reorganizing to respond to economic and health care changes, Gawreluk said in her email to the newspaper.
DePuy Synthes, she wrote, will offer more products to hospitals, improve innovation, offer expert guidance to orthopedic surgeons and cut costs, among other goals.
“As we transform our operating model, the majority of our employee roles won’t change or will change minimally. New roles are being created and other roles are being eliminated,” she wrote, adding that about 80 new positions have been created to help the company execute its new strategy.
Gawreluk declined to say how many of those new jobs will be in Warsaw.
“We hope impacted employees will strongly consider these positions as well as career opportunities across Johnson & Johnson,” she said. DePuy Synthes is a Johnson & Johnson company.
For those whose jobs are eliminated, the company is offering severance benefits and job placement assistance.